Status:
COMPLETED
Palliative Care for Patients With Advanced Heart Disease
Lead Sponsor:
University of Edinburgh
Conditions:
Acute Coronary Syndrome
Congestive Cardiac Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Patients admitted as an unscheduled hospital admission with either a acute heart failure syndrome (ACF) or acute coronary syndrome (ACS) will be eligible if their 6-12 month mortality risk is estimate...
Detailed Description
Patients with either acute coronary syndrome(ACS) or acute heart failure (AHF) achieving an estimated risk of mortality within 12 months of 20% or greater (GRACE score for ACS and EFFECT score for AHF...
Eligibility Criteria
Inclusion
- Age \> 18 years Unscheduled hospital admission due to congestive heart failure and or acute coronary syndrome 12 month estimated mortality risk of 20% or greater Optimal tolerated medical and device therapy
Exclusion
- Expected survival \< 28 days Other life limiting non-cardiac condition likely to cause death within 12 months Moderate or severe dementia Moderate or severe cognitive impairment
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02302014
Start Date
August 1 2013
End Date
May 1 2015
Last Update
December 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Infirmary of Edinburgh
Edinburgh, Scotland, United Kingdom, EH16 4SA